Targeted treatment of active trachoma [6]

JAMA

Volumn 297, Issue 6, 2007, Pages 588-

  Mabey, David ^a   Bailey, Robin ^a   Solomon, Anthony ^a   Burton, Matthew ^a   Gilbert, Clare ^a   Foster, Allen ^a   Lietman, Thomas ^b   West, Sheila ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COMMUNITY; DISEASE DURATION; HERD IMMUNITY; HUMAN; IMMUNE RESPONSE; INFECTION SENSITIVITY; LETTER; PREVALENCE; PRIORITY JOURNAL; REINFECTION; SYSTEMIC THERAPY; TRACHOMA; TREATMENT OUTCOME; TRICHIASIS; VARIANCE; VIET NAM;

EID: 33846995627     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.6.588-a     Document Type: Letter

References (5)

1. Atik B, Thanh TT, Luong VQ, Lagree S, Dean D. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. JAMA. 2006;296:1488-1497.
2. Bailey R, Duong T, Carpenter R, Whittle H, Mabey D. The duration of human ocular chlamydial infection is age dependent. Epidemiol Infect. 1999;123:479-486.
3. Schachter J, West S, Mabey D, et al. Azithromycin in control of trachoma: effect of community wide treatment on Chlamydia trachomatis infection. Lancet. 1999;354:630-635.
4. Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med. 2004;351:1962-1971.
5. Chidambaram JD, Alemayehu W, Melese M, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA. 2006;295:1142-1146.